Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot?
Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?
And here is our regular feature in which we highlight a different person each week. This time around, we note that Neon Therapeutics hired Dr. Richard Gaynor as president of research and development. Most recently, he worked at Eli Lilly, where he was senior vice president of global product development and medical affairs.
Teva Pharmaceuticals hired David Stark as chief legal officer;
Akriveia Therapeutics hired Dr. C. Glenn Begley as chief scientific officer;
Akriveia Therapeutics hired Margaret Karow as vice president of discovery and preclinical development;
Adare Pharmaceuticals hired Dr. Peter Richardson as vice president, R&D, and chief medical officer;
Eutilex hired Agustin de la Calle as chief business officer;
Cipher Pharmaceuticals named Stephen Lemieux as interim chief executive officer;
Cipher Pharmaceuticals says that chief executive officer Shawn O’Brien is leaving;
Harpoon Therapeutics hired Hans-Peter Gerber as chief scientific officer;
DisperSol Technologies hired Edward Rudnic as chief executive officer;
Oncolytics Biotech hired Dr. Andres Gutierrez as chief medical officer;
MorphoSys hired Anke Linnartz as vice president and head of corporate communications and investor relations;
AvroBio hired Dr. Nerissa Kreher as chief medical officer for rare diseases;
AvroBio hired Kathryn McNaughton as senior vice president of portfolio and program management;
AvroBio hired Richard Pfeifer as director preclinical development;
Vasopharm hired Dr. Irina Antonijevic as chief medical officer.
About the Author Reprints
